EpiEndo Pharmaceuticals is a startup based in Iceland, 1 tracked investor.
Based in Iceland, EpiEndo Pharmaceuticals is a startup. Brouky records 1 investor associated with the company.
EpiEndo Pharmaceuticals is a clinical-stage biopharmaceutical company developing glasmacinal, an oral non-antibiotic macrolide intended to reduce exacerbations in COPD patients. The candidate is designed to retain macrolide anti-inflammatory and host-defense properties while lacking antibacterial activity to avoid promoting antimicrobial resistance.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.